Carregant...
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical condition characterized by large pathophysiology heterogeneity with lack of effective therapies as proven by the disappointing results generated by randomized controlled trials. The innovative therapeutic concept provided by s...
Guardat en:
| Publicat a: | Eur Heart J Suppl |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7944492/ https://ncbi.nlm.nih.gov/pubmed/33727901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa140 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|